Compound ID | 89
S201
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against Escherichia coli and Klebsiella pneumonia |
| Combined with other compounds: | Yes |
| Description: | A cephalosporin |
| Institute where first reported: | Sopharmia Inc, USA |
| Year first mentioned: | 2014 |
| Development status: | Experimental |
| External links: | |
| Citation: | http://gladiuspharma.com/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.